Jun Cai
Yangzhou University
15 Papers
29 Citations
Jun Cai is an academic researcher from Yangzhou University. The author has contributed to research in topics: Medicine & Spinal cord injury. The author has an hindex of 7, co-authored 15 publications. Previous affiliations of Jun Cai include Nanjing Medical University.
Chat about Author
Papers
A comparison of high viscosity bone cement and low viscosity bone cement vertebroplasty for severe osteoporotic vertebral compression fractures
Liang Zhang,Jingcheng Wang,Xinmin Feng,Yuping Tao,Jiandong Yang,Yongxiang Wang,Shengfei Zhang,Jun Cai,Jijun Huang +8 more
TL;DR: The PVP using high viscosity bone cement can provide the same clinical outcome and fewer complications compared with PVP use low viscosities bone cement.
56
Cement injection and postoperative vertebral fractures during vertebroplasty
TL;DR: Bone cement injection volume, BMD values, and sex were statistically significantly related to adjacent vertebra fractures after vertebroplasty, and cement injection volumes exceeding 40.5% caused adjacent vertebral fractures.
Necrosulfonamide Attenuates Spinal Cord Injury via Necroptosis Inhibition.
TL;DR: Research indicates NSA attenuates the spinal cord injury via necroptosis inhibition and might be a potential and safe chemical benefit for SCI therapy.
24
The optimal concentration of topical hydroxycamptothecin in preventing intraarticular scar adhesion
Yuan Liang,Yu Sun,Xiaolei Li,Lianqi Yan,Jingcheng Wang,Jinlong Hu,Huan Yu,Haixiang Xiao,Hui Chen,Zhongwei Sun,Jun Cai,Xinmin Feng,Chuanzhi Xiong,Jinshan He +13 more
TL;DR: In this paper, the optimal 10-hydroxycamptothecin concentration for knee intraarticular adhesion after knee surgery was evaluated in 60 rabbits and showed that topical application of 1.0 mg/ml may be the optimal concentration.
Outcome Evaluation of Zero-Profile Device Used for Single-Level Anterior Cervical Discectomy and Fusion with Osteoporosis Compared without Osteoporosis: A Minimum Three-Year Follow-Up Study.
Liang Zhang,Jingcheng Wang,Xinmin Feng,Yuping Tao,Jiandong Yang,Yongxiang Wang,Shengfei Zhang,Jun Cai +7 more
TL;DR: ACDF with the Zero-Profile device can be used as an effective and reliable treatment for single-level CDDD with osteoporosis.
15